Pacific Biosciences of California Inc

9 de set. de 2026, 20:01 UTC

Pacific Biosciences of California shares are lower after UBS initiated coverage with a Neutral rating and a price target of $1.35.

8 de set. de 2026, 23:56 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, despite fluctuations, and remain above their 20-day moving average.

3 de set. de 2026, 19:56 UTC

Pacific Biosciences of California is lower today with no specific news. The broader market sees falling Treasury yields amid jobless claims data.

2 de set. de 2026, 23:46 UTC

Pacific Biosciences of California is higher in after-market trading, despite no specific news, amid a weaker ADP payrolls report that may ease rate hike concerns.

1 de set. de 2026, 23:46 UTC

Pacific Biosciences of California remained roughly flat during after-market hours. This follows five consecutive sessions of lower finishes.

31 de ago. de 2026, 20:07 UTC

Pacific Biosciences is trading lower, reflecting broader market declines amid heightened interest rate hike expectations from the Jackson Hole Economic Symposium.

28 de ago. de 2026, 23:36 UTC

Pacific Biosciences is trading higher in after-market hours, reaching a level significantly above Friday's close amid broader market pressures from rising Treasury yields.

27 de ago. de 2026, 20:07 UTC

Pacific Biosciences of California is lower today, with no specific news driving the decline. The broader market has also been down since Wednesday.

26 de ago. de 2026, 23:06 UTC

Pacific Biosciences of California traded roughly flat in after-market hours, with no specific news driving the activity. The stock remains near its one-month range's upper end.

25 de ago. de 2026, 23:01 UTC

Pacific Biosciences is lower in after-market trading, with no specific news identified. The broader market has also retreated amid falling crude oil prices.

24 de ago. de 2026, 23:01 UTC

Pacific Biosciences of California is trading higher in after-hours, recovering from an initial low and remaining above its 20-day moving average.

21 de ago. de 2026, 22:51 UTC

Shares of Pacific Biosciences of California declined in after-market trading, continuing a downward trend amid broader market weakness and rising Treasury yields.

20 de ago. de 2026, 19:51 UTC

Pacific Biosciences is lower today, reflecting broader market declines and trading near the lower end of its one-month range.

19 de ago. de 2026, 23:11 UTC

Pacific Biosciences of California shows a modest increase in after-market trading, reflecting stability amid a broader positive trend in correlated assets.

18 de ago. de 2026, 23:16 UTC

Pacific Biosciences shares declined in after-hours trading, continuing a downward trend since Tuesday's close, amid broader market sentiment reflected by the Russell 2000 Index.

17 de ago. de 2026, 19:11 UTC

Pacific Biosciences reported second-quarter revenue of $39 million, with shares trading higher today after initially dropping. The company is undergoing a leadership transition.

14 de ago. de 2026, 19:36 UTC

Pacific Biosciences reported second-quarter revenue of $39.01 million, missing estimates. Shares are trading lower amid concerns over funding constraints and adoption challenges.

13 de ago. de 2026, 23:06 UTC

Pacific Biosciences of California Inc. gained modestly in after-market trading, reflecting broader market trends seen in correlated assets.

12 de ago. de 2026, 23:41 UTC

Pacific Biosciences shares are lower in after-market hours, trading below their 20-day moving average amid easing inflation concerns and broader market conditions.

11 de ago. de 2026, 20:06 UTC

Pacific Biosciences of California is trading higher in a routine session. The stock remains below its 20-day moving average despite today's gains.

10 de ago. de 2026, 23:21 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, recovering from earlier losses and gaining since Monday's close.

7 de ago. de 2026, 22:56 UTC

Pacific Biosciences shares are lower in after-market trading, retracing from an initial gain as 10X Genomics declines, impacting market sentiment.

6 de ago. de 2026, 23:11 UTC

Pacific Biosciences of California is higher in after-market trading, reflecting positive momentum since Thursday's close, despite being below its 20-day moving average.

5 de ago. de 2026, 23:01 UTC

Pacific Biosciences reported lower second-quarter revenue and a wider EPS loss, prompting a reduction in full-year sales guidance. Shares are down in after-market trading.

4 de ago. de 2026, 21:36 UTC

Pacific Biosciences of California remained roughly flat after market hours. Broader market gains were driven by a decline in crude oil prices.

3 de ago. de 2026, 23:36 UTC

Pacific Biosciences of California Inc. shares are roughly flat after-market, remaining near the lower end of their one-month trading range.

31 de jul. de 2026, 19:46 UTC

Pacific Biosciences of California is trading lower amid a report citing annual sales declines and cash burn concerns impacting its growth outlook.

29 de jul. de 2026, 16:06 UTC

Pacific Biosciences of California Inc shares are lower today, reflecting broader market pressure on small-cap equities and a notable decline in correlated assets.

28 de jul. de 2026, 16:12 UTC

Pacific Biosciences is trading higher, rebounding from earlier losses despite broader market caution following declines in the Nikkei 225 Index.

27 de jul. de 2026, 19:06 UTC

Pacific Biosciences is trading higher as the broader market rises, supported by a notable decline in crude oil prices that has eased geopolitical tensions.